Related Experiment Video

Updated: Nov 24, 2025

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.7K

Developmental and epileptic encephalopathies: Is prognosis related to different epileptic network dysfunctions?

Jainn-Jim Lin1, Stefano Meletti2, Anna Elisabetta Vaudano2

  • 1Division of Pediatric Critical Care and Pediatric Neurocritical Care Center, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Graduate Institute of Clinical Medical Sciences, Chang Gung University, College of Medicine, Taoyuan, Taiwan; Division of Pediatric Neurology, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Department of Respiratory Therapy, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan; Study Group for Intensive and Integrated Care of Pediatric Central Nervous System (iCNS Group), Chang Gung Children's Hospital, Taoyuan, Taiwan.

Epilepsy & Behavior : E&B
|December 22, 2020
PubMed

Insights

Developmental and epileptic encephalopathies (DEEs) are severe epilepsies with refractory seizures and developmental issues. Recent research focuses on epileptic network dysfunction rather than just lesions, guiding holistic precision therapies.

Area of Science:

  • Neurology
  • Genetics
  • Epileptology

Background:

  • Developmental and epileptic encephalopathies (DEEs) are rare, severe conditions presenting with refractory seizures and developmental delays or regression.
  • While developmental changes can occur independently, epileptic activity often exacerbates cognitive and behavioral deficits.
  • The understanding of DEEs is shifting from lesion-based to epileptic network dysfunction.

Purpose of the Study:

  • To review the evolving concept of DEEs.
  • To summarize the current knowledge on the genetic underpinnings of DEEs.
  • To discuss the impact of epileptic network dysfunction on DEE prognosis.

Main Methods:

  • Literature review of recent advancements in DEE research.
  • Analysis of studies focusing on genetic etiologies.
  • Examination of research on brain network function in DEEs.

Main Results:

  • DEE concept evolution towards network dysfunction.
  • Advancements in understanding genetic bases.
  • Epileptic network dysfunction identified as a key prognostic factor.

Conclusions:

  • Early recognition and differentiation are crucial for effective, holistic precision therapies in DEEs.
  • Understanding genetic factors and network dysfunctions is key to improving patient outcomes.
  • Focus on epileptic network dysfunction offers new therapeutic avenues for severe epilepsies.

Keywords:
Developmental and epileptic encephalopathiesEpileptic network dysfunctionGenetic mutationPrognosis

More Related Videos

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.1K
Network Analysis of the Default Mode Network Using Functional Connectivity MRI in Temporal Lobe Epilepsy12:09

Network Analysis of the Default Mode Network Using Functional Connectivity MRI in Temporal Lobe Epilepsy

Published on: August 5, 2014

18.3K

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
905
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
964
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
440